tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 222 are a BUY (87.4%), 31 are a HOLD (12.2%), 1 are a SELL (0.39%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 41.78% that have a potential upside of 62.65% achieved within 180 days.
Robert Driscoll’s has documented 511 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TYRA, Tyra Biosciences at 16-Dec-2025.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 15-Sep-2020
$5
$0.19 (3.95%)
$5
1 months 25 days ago
(14-Nov-2025)
4/14 (28.57%)
$0.44 (9.65%)
136
Buy
Since 08-Dec-2021
$5
$0.19 (3.95%)
$5
11 months 18 days ago
(21-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
Since 28-Jun-2022
$5
$0.19 (3.95%)
$4
1 years 5 months 6 days ago
(02-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
Since 02-Feb-2022
$5
$0.19 (3.95%)
3 years 11 months 6 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
Since 27-Jul-2020
$7
4 years 6 months 11 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
